These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 31064068)

  • 1. Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors.
    Koga Y; Ochiai A
    Cells; 2019 May; 8(5):. PubMed ID: 31064068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer.
    Wang Y; Cui J; Wang L
    Chin Clin Oncol; 2019 Apr; 8(2):17. PubMed ID: 30943729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.
    Zarzosa P; Navarro N; Giralt I; Molist C; Almazán-Moga A; Vidal I; Soriano A; Segura MF; Hladun R; Villanueva A; Gallego S; Roma J
    Clin Transl Oncol; 2017 Jan; 19(1):44-50. PubMed ID: 27718156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived xenograft (PDX) models, applications and challenges in cancer research.
    Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K
    J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.
    Sun S; Zhang Z
    Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of transcriptome in cancer patient-derived xenografts.
    Li H; Zhu Y; Tang X; Li J; Li Y; Zhong Z; Ding G; Li Y
    PLoS One; 2015; 10(5):e0124780. PubMed ID: 25951608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification.
    Oh DY; Jung K; Song JY; Kim S; Shin S; Kwon YJ; Oh E; Park WY; Song SY; Choi YL
    BMC Cancer; 2017 Aug; 17(1):535. PubMed ID: 28806950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer.
    Chen Z; Huang W; Tian T; Zang W; Wang J; Liu Z; Li Z; Lai Y; Jiang Z; Gao J; Shen L
    J Hematol Oncol; 2018 Feb; 11(1):20. PubMed ID: 29433585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance.
    Shi J; Li Y; Jia R; Fan X
    Int J Cancer; 2020 Apr; 146(8):2078-2088. PubMed ID: 31479514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review.
    Brown KM; Xue A; Mittal A; Samra JS; Smith R; Hugh TJ
    Oncotarget; 2016 Oct; 7(40):66212-66225. PubMed ID: 27517155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
    Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
    Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinical implementations of ovarian cancer mouse avatar models.
    Zayed AA; Mandrekar SJ; Haluska P
    Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.
    Liu JF; Palakurthi S; Zeng Q; Zhou S; Ivanova E; Huang W; Zervantonakis IK; Selfors LM; Shen Y; Pritchard CC; Zheng M; Adleff V; Papp E; Piao H; Novak M; Fotheringham S; Wulf GM; English J; Kirschmeier PT; Velculescu VE; Paweletz C; Mills GB; Livingston DM; Brugge JS; Matulonis UA; Drapkin R
    Clin Cancer Res; 2017 Mar; 23(5):1263-1273. PubMed ID: 27573169
    [No Abstract]   [Full Text] [Related]  

  • 15. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
    Jung J; Seol HS; Chang S
    Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DRAP: a toolbox for drug response analysis and visualization tailored for preclinical drug testing on patient-derived xenograft models.
    Li Q; Dai W; Liu J; Li YX; Li YY
    J Transl Med; 2019 Jan; 17(1):39. PubMed ID: 30696439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
    Kawaguchi T; Foster BA; Young J; Takabe K
    J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Knowledge and practice of patient-derived xenograft models in leukemia].
    Kato I
    Rinsho Ketsueki; 2022; 63(9):1335-1343. PubMed ID: 36198560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of patient-derived tumor xenografts in cancer treatment.
    Sia D; Moeini A; Labgaa I; Villanueva A
    Pharmacogenomics; 2015; 16(14):1671-83. PubMed ID: 26402657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Derived Xenograft Models of Breast Cancer and Their Application.
    Murayama T; Gotoh N
    Cells; 2019 Jun; 8(6):. PubMed ID: 31226846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.